News in brief: MedReleaf expands product range; Bioxyne receives first psilocybin order; Greencare names medical lead by Steve Jones February 11, 2026February 12, 2026 MedReleaf Australia has expanded its product range in Australia and New Zealand with the addition of […]
Vitura JV to take delivery of first batch of psychedelic medicines by cannabiz team July 26, 2023April 30, 2024
Company news: Vitura Health; Puro; MGC Pharma; Incannex; Cann Global by Steve Jones March 8, 2023April 30, 2024
Company news: Delta 9 Cannabis; Little Green Pharma; Zelira Therapeutics; Emyria by Martin Lane and Steve Jones February 16, 2023April 30, 2024
Emyria and LGP shares soar after TGA approves limited access to MDMA and psilocybin by Steve Jones February 6, 2023April 29, 2024
Company news: Medlab Clinical; Helius Therapeutics; Creso Pharma by cannabiz team November 9, 2021April 29, 2024
Monash University receives ethics approval for psilocybin trial where the therapists get to test the treatment by Martin Lane October 28, 2021April 29, 2024
TGA releases findings on MDMA and psilocybin as mental health treatments by Martin Lane October 5, 2021April 26, 2024
Little Green Pharma launches psychedelic medicines division by Hannah Adler September 8, 2021April 26, 2024
